Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delirium | 13 | 2024 | 1696 | 2.270 |
Why?
|
Atrophy | 6 | 2024 | 1646 | 1.200 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 3 | 2017 | 558 | 0.840 |
Why?
|
CADASIL | 2 | 2015 | 83 | 0.820 |
Why?
|
Fatigue | 5 | 2020 | 1557 | 0.560 |
Why?
|
Postoperative Complications | 10 | 2024 | 15833 | 0.520 |
Why?
|
Hypertensive Retinopathy | 1 | 2015 | 4 | 0.510 |
Why?
|
Multiple Sclerosis | 7 | 2020 | 3250 | 0.490 |
Why?
|
Brain | 11 | 2020 | 27362 | 0.450 |
Why?
|
Diffusion Tensor Imaging | 5 | 2018 | 2420 | 0.420 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2015 | 252 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 16 | 2024 | 36741 | 0.380 |
Why?
|
Leukoencephalopathies | 1 | 2014 | 259 | 0.360 |
Why?
|
Fractals | 1 | 2011 | 127 | 0.350 |
Why?
|
Cerebral Cortex | 2 | 2024 | 5812 | 0.350 |
Why?
|
Retinal Vessels | 2 | 2015 | 864 | 0.320 |
Why?
|
Disease Progression | 5 | 2017 | 13668 | 0.310 |
Why?
|
Corpus Striatum | 2 | 2014 | 1224 | 0.310 |
Why?
|
Thalamus | 1 | 2014 | 1047 | 0.290 |
Why?
|
Alzheimer Disease | 3 | 2024 | 8759 | 0.290 |
Why?
|
Preoperative Care | 1 | 2016 | 2258 | 0.270 |
Why?
|
Retina | 1 | 2015 | 2662 | 0.230 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2815 | 0.230 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3390 | 0.200 |
Why?
|
Aged | 23 | 2024 | 171502 | 0.180 |
Why?
|
Selection Bias | 1 | 2022 | 360 | 0.170 |
Why?
|
Anisotropy | 3 | 2018 | 1292 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59626 | 0.140 |
Why?
|
Xanthurenates | 1 | 2015 | 6 | 0.130 |
Why?
|
Male | 25 | 2024 | 364731 | 0.130 |
Why?
|
Female | 24 | 2024 | 397187 | 0.120 |
Why?
|
Neuropsychological Tests | 4 | 2020 | 7140 | 0.120 |
Why?
|
Interleukin-6 | 1 | 2024 | 3229 | 0.120 |
Why?
|
Humans | 35 | 2024 | 768171 | 0.120 |
Why?
|
Cephalometry | 1 | 2016 | 380 | 0.110 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2015 | 196 | 0.110 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2014 | 81 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14783 | 0.110 |
Why?
|
Organ Size | 2 | 2016 | 2267 | 0.110 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3858 | 0.100 |
Why?
|
Quantitative Trait, Heritable | 1 | 2015 | 540 | 0.100 |
Why?
|
Anticarcinogenic Agents | 1 | 2014 | 251 | 0.100 |
Why?
|
Skull | 1 | 2016 | 829 | 0.090 |
Why?
|
Carbamazepine | 1 | 2012 | 224 | 0.090 |
Why?
|
Carotenoids | 1 | 2014 | 620 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54924 | 0.080 |
Why?
|
Middle Aged | 13 | 2020 | 223487 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1535 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15949 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10873 | 0.070 |
Why?
|
Adult | 12 | 2020 | 223646 | 0.070 |
Why?
|
Opioid Peptides | 1 | 2006 | 37 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39354 | 0.070 |
Why?
|
Apomorphine | 1 | 2006 | 148 | 0.070 |
Why?
|
Ischemic Attack, Transient | 1 | 2011 | 877 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 1 | 2012 | 1165 | 0.060 |
Why?
|
Brain Ischemia | 2 | 2012 | 3007 | 0.060 |
Why?
|
Telencephalon | 1 | 2006 | 143 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2016 | 2725 | 0.060 |
Why?
|
Aging | 3 | 2023 | 8743 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6340 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2006 | 2230 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26379 | 0.050 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
Dopamine Agonists | 1 | 2006 | 347 | 0.050 |
Why?
|
Cohort Studies | 3 | 2019 | 41753 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2012 | 2055 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2023 | 22290 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4064 | 0.050 |
Why?
|
Time Factors | 1 | 2024 | 40220 | 0.050 |
Why?
|
Hippocampus | 1 | 2015 | 3783 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4672 | 0.050 |
Why?
|
Lysine | 1 | 2006 | 1000 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2023 | 563 | 0.040 |
Why?
|
Incidence | 2 | 2016 | 21538 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3706 | 0.040 |
Why?
|
Stroke | 2 | 2012 | 9755 | 0.040 |
Why?
|
Schizophrenia | 1 | 2015 | 6983 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20762 | 0.030 |
Why?
|
Young Adult | 3 | 2017 | 60066 | 0.030 |
Why?
|
Synaptic Membranes | 1 | 2015 | 89 | 0.030 |
Why?
|
Kynurenine | 1 | 2015 | 142 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 30009 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2006 | 3140 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14164 | 0.030 |
Why?
|
Glucose | 1 | 2006 | 4352 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20225 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2018 | 752 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1489 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11101 | 0.020 |
Why?
|
Cerebellum | 1 | 2018 | 1522 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2019 | 81760 | 0.020 |
Why?
|
Axons | 1 | 2018 | 1677 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2018 | 6229 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14729 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1379 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3912 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8741 | 0.020 |
Why?
|
Dopamine | 2 | 2006 | 1592 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5884 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15453 | 0.020 |
Why?
|
Electroencephalography | 1 | 2022 | 6314 | 0.020 |
Why?
|
Gerbillinae | 1 | 2006 | 87 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8890 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4280 | 0.020 |
Why?
|
MPTP Poisoning | 1 | 2006 | 37 | 0.020 |
Why?
|
Metabolomics | 1 | 2015 | 1674 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 2006 | 171 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10590 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6669 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8747 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9343 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74944 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2080 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6512 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2006 | 663 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2012 | 1923 | 0.010 |
Why?
|
Analgesia | 1 | 2006 | 460 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9016 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9613 | 0.010 |
Why?
|
Depression | 1 | 2019 | 8230 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8509 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 2006 | 859 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8142 | 0.010 |
Why?
|
Mice | 2 | 2015 | 82049 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10763 | 0.010 |
Why?
|
Animals | 3 | 2015 | 169285 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2012 | 65379 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23648 | 0.010 |
Why?
|
Hospitalization | 1 | 2011 | 10840 | 0.010 |
Why?
|
Risk Assessment | 1 | 2011 | 24318 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23782 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22380 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18349 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_